T5	Subject 0 9	Patient B
T6	Effect 20 61	perioral and upper extremity paresthesias
T8	Treatment 69 111	the fourth cycle of CAP alone (2500 mg/m2)
T9	Drug 89 92	CAP
T10	Freq 69 85	the fourth cycle
T11	Dosage 100 110	2500 mg/m2
T7	Adverse_event 10 19	developed
E1	Adverse_event:T7